Breaking News
4846 - 4860 of 6634 results
Prev
322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443
Next
June 10, 2008
Daniel G. Franklin has been appointed regional manager, compliance services, Integrated Project Services (IPS), based in Indiana. Also, Matthew Stefanowicz has been appointed regional manager, compliance services based in North Carolina.
 …
Read More »
June 10, 2008
Cold Chain Technologies (CCT) has opened its new plant in Reno, NV and has expanded its plants in Massachusetts and Tennessee, doubling its Massachusetts thermal testing facility. Also, CCT has named Jeff Bernardi, Reno plant manager and Jamie Chaste…
Read More »
June 9, 2008
Anna S. Richo has been appointed senior vice president, Worldwide Compliance, Amgen. Ms. Richo will head the organization responsible for the company’s corporate compliance and business ethics programs. She will report to Amgen chairman and chi…
Read More »
June 9, 2008
Takeda Global R&D Center reported results from five Phase III studies of alogliptin as an oral treatment for type 2 diabetes, which has been shown to be a highly selective inhibitor of dipeptidyl peptidase-4 (DPP-4). Alogliptin administered once…
Read More »
June 9, 2008
Amylin Pharmaceuticals, Lilly and Alkermes announced results from a 30-week study comparing the efficacy of exenatide once weekly (a long-acting release formulation of exenatide) to Byetta (the injectable version of exenatide), in type 2 diabetes. Pa…
Read More »
June 6, 2008
Patheon
2Q Revenues: $186 million (16%)
2Q Loss: $8.5 million (loss of $22 million in 2Q07)
YTD Revenues: $350 million (+14%)
YTD Loss: $23.7 million (loss of $24 million YTD07)
Comments: Commercial manufacturing revenues in the quarte…
Read More »
June 6, 2008
GlaxoSmithKline has completed its acquisition of Sirtris Pharmaceuticals, Inc. for approximately $720 million in cash. Through the acquisition GSK has enhanced its metabolic, neurology, immunology and inflammation research efforts by establishing a p…
Read More »
June 6, 2008
Charles E. Triano has been named senior vice president, investor relations, Pfizer, effective June 23. Mr. Triano will be responsible for all investor relations functions, including communicating the financial and operational performance of the compa…
Read More »
June 5, 2008
Ipsen, S.A. and Tercica have entered into a definitive merger agreement under which an affiliate of Ipsen will acquire all outstanding shares (approximately 43%) of Tercica for approximately $663 million in cash. This transaction, which is subject to…
Read More »
June 5, 2008
Merck Serono and development partner ZymoGenetics have initiated a Phase II/III trial of atacicept in patients with systemic lupus erythematosus (SLE) to evaluate the efficacy and safety of the drug for the treatment of SLE.
The study is being con…
Read More »
June 5, 2008
Michael Faughnan has been named business development director of Eden Biodesign's U.S. subsidiary, Eden Biodesign, Inc. He will support Dr. Roger Lias, president of Eden Biodesign, Inc. and group commercial director, with the company’s expansio…
Read More »
June 4, 2008
Novartis plans to acquire Protez Pharmaceuticals for as much as $400 million. Protez is a privately held biotechnology company based in Malvern, PA. Its lead drug candidate, PZ-601, is an injectable antibiotic in Phase II development for the potentia…
Read More »
June 4, 2008
Microtest Laboratories has doubled its microbial identification and analytical services with the purchase of an additional MicroSeq Microbial Identification System. The MicroSeq is a DNA sequence-based system used to identify bacteria isolates that a…
Read More »
June 4, 2008
Kathleen Hodges has been appointed to the new position of vice president of quality, BASi (Bioanalytical Systems, Inc.). Ms. Hodges has corporate-wide responsibility for all matters relating to quality and regulatory issues. She has a background in q…
Read More »
June 3, 2008
Patheon, Inc. has established a Japanese subsidiary based in Tokyo, Japan. Patheon K.K. will operate from a new office located in the Nihonbashi district of central Tokyo and will support Patheon's business requirements in the region. Local staff wil…
Read More »
4846 - 4860 of 6634 results
Prev
322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443
Next



